Comparison Chart LifeTech Scientific Corporation

Equities

Market Closed - Hong Kong S.E. Other stock markets 04:08:17 2024-05-17 am EDT			5-day change	1st Jan Change
1.93 ^HKD	+2.12%		+9.66%	-17.87%

May. 16	LifeTech Scientific Completes Follow-up of Phase 2 Clinical Study of IBS Coronary Scaffold	MT
May. 15	LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	LIFETECH SCIENTIFIC CORPORATION	Other Advanced Medical Equipment & Technology	+2.12%	+9.66%	-17.87%	-24.90%	+22.93%	1.12B